| Cisplatin | Approved Investigational | COA7 | 65260 |
downregulated | Cisplatin results in decreased expression of COA7 mRNA | 1p32.3 | |
| Cisplatin | Approved Investigational | COCH | 1690 |
upregulated | Cisplatin results in increased expression of COCH mRNA | 14q12 | |
| Cisplatin | Approved Investigational | COL13A1 | 1305 |
downregulated | Cisplatin results in decreased expression of COL13A1 mRNA | 10q22.1 | |
| Cisplatin | Approved Investigational | COL4A1 | 1282 |
downregulated | Cisplatin results in decreased expression of COL4A1 mRNA | 13q34 | |
| Cisplatin | Approved Investigational | COQ8A | 56997 |
upregulated | Cisplatin results in increased expression of COQ8A mRNA | 1q42.13 | |
| Cisplatin | Approved Investigational | CPT2 | 1376 |
downregulated | Cisplatin results in decreased expression of CPT2 mRNA | 1p32.3 | |
| Cisplatin | Approved Investigational | CRELD2 | 79174 |
upregulated | Cisplatin results in increased expression of CRELD2 mRNA | 22q13.33 | |
| Cisplatin | Approved Investigational | CRIP2 | 1397 |
upregulated | Cisplatin results in increased expression of CRIP2 mRNA | 14q32.33 | |
| Cisplatin | Approved Investigational | CRYAB | 1410 |
upregulated | Cisplatin results in increased expression of CRYAB mRNA | 11q23.1 | |
| Cisplatin | Approved Investigational | CTDP1 | 9150 |
downregulated | Cisplatin results in decreased expression of CTDP1 mRNA | 18q23 | |
| Cisplatin | Approved Investigational | CTH | 1491 |
upregulated | Cisplatin results in increased expression of CTH mRNA | 1p31.1 | |
| Cisplatin | Approved Investigational | CTSC | 1075 |
upregulated | Cisplatin results in increased expression of CTSC mRNA | 11q14.2 | |
| Cisplatin | Approved Investigational | CTTN | 2017 |
upregulated | Cisplatin results in increased expression of CTTN mRNA | 11q13.3 | |
| Cisplatin | Approved Investigational | CWC27 | 10283 |
downregulated | Cisplatin results in decreased expression of CWC27 mRNA | 5q12.3 | |
| Cisplatin | Approved Investigational | CXCL8 | 3576 |
downregulated | Cisplatin results in decreased expression of CXCL8 mRNA | 4q13.3 | |
| Cisplatin | Approved Investigational | CYP1A1 | 1543 |
downregulated | Cisplatin results in decreased expression of CYP1A1 mRNA | 15q24.1 | |
| Cisplatin | Approved Investigational | CYP1B1 | 1545 |
upregulated | Cisplatin results in increased expression of CYP1B1 mRNA | 2p22.2 | |
| Cisplatin | Approved Investigational | CYP3A4 | 1576 |
upregulated | Cisplatin results in increased expression of CYP3A4 mRNA | 7q22.1 | |
| Cisplatin | Approved Investigational | CYP4A11 | 1579 |
upregulated | Cisplatin results in increased expression of CYP4A11 mRNA | 1p33 | |
| Cisplatin | Approved Investigational | CYTOR | 112597 |
upregulated | Cisplatin results in increased expression of CYTOR mRNA | 2p11.2 | |
| Cisplatin | Approved Investigational | DAD1 | 1603 |
upregulated | Cisplatin results in increased expression of DAD1 mRNA | 14q11.2 | |
| Cisplatin | Approved Investigational | DBNL | 28988 |
downregulated | Cisplatin results in decreased expression of DBNL mRNA | 7p13 | |
| Cisplatin | Approved Investigational | DCBLD2 | 131566 |
downregulated | Cisplatin results in decreased expression of DCBLD2 mRNA | 3q12.1 | |
| Cisplatin | Approved Investigational | DDB2 | 1643 |
upregulated | Cisplatin results in increased expression of DDB2 mRNA | 11p11.2 | |
| Cisplatin | Approved Investigational | DDIAS | 220042 |
downregulated | Cisplatin results in decreased expression of DDIAS mRNA | 11q14.1 | |